(Q53216205)

English

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma.

scientific article published in July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Adaptive radiation therapy

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

Tomohiko Yamane

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shogo Shinohara

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Masahiro Kikuchi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Keizo Fujiwara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shin-ya Hori

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yosuke Tona

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Hiroshi Yamazaki

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yasushi Naito

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Michio Senda

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Annals of Nuclear Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

625-633

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720778%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

https://scigraph.springernature.com/pub.10.1007/s12149-011-0508-9

0 references

Tumor angiogenesis and accessibility: role of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Influence of haemoglobin concentration and peripheral muscle pO2 on tumour oxygenation in advanced head and neck tumours.

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Hypoxic Sensitizers — Implications for Radiation Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Synthesis and biodistribution of 18F-labeled fluoronitroimidazoles: potential in vivo markers of hypoxic tissue

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Reduction of [(18)F]fluoromisonidazole uptake after neoadjuvant chemotherapy for head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Fully automated one-pot synthesis of [18F]fluoromisonidazole

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Fully automated synthesis of [18F]fluoromisonidazole using a conventional [18F]FDG module

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

The K(m) for Radiosensitization of Human Tumor Cells by Oxygen is Much Greater than 3 mmHg and is Further Increased by Elevated Levels of Cysteine

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia.

1 reference

https://api.crossref.org/works/10.1007%2FS12149-011-0508-9

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53216205&oldid=1513236125"